Investigation Report on China's Sitagliptin Market 2021-2025

SKU ID :CRI-18465161 | Published Date: 04-Jun-2021 | No. of pages: 50
1 Relevant Concepts of Sitagliptin 1.1 Indications for Sitagliptin 1.2 Development of Sitagliptin in China 1.3 Governmental Approval of Sitagliptin in China 1.4 The Impact of COVID-19 on Sitagliptin sales in China 2 Sales of Sitagliptin in China, 2016-2020 2.1 Sales Value of Sitagliptin 2.1.1 Overall Sales Value 2.1.2 Sales Value by Region 2.2 Sales Volume of Sitagliptin 2.2.1 Overall Sales Volume 2.2.2 Sales Volume by Region 2.3 Sales of Sitagliptin by Dosage Form in China, 2016-2020 2.3.1 Tablets 2.3.2 Analysis of Other Dosage Forms 3 Analysis of Major Sitagliptin Manufacturers in China, 2016-2020 3.1 Analysis of Market Share of Major Sitagliptin Manufacturers 3.1.1 Investigation on Market Share by Sales Value 3.1.2 Investigation on Market Share by Sales volume 3.2 Merck Sharp & Dohme Ltd 3.2.1 Enterprise Profile 3.2.2 Sales of JANUVIA (Merck Sharp & Dohme Ltd's Sitagliptin) in China 4 Prices of Sitagliptin for Different Manufacturers in China, 2020-2021 4.1 Merck Sharp & Dohme Ltd (JANUVIA) 4.2 Analysis of Other Enterprises 5 Prospect of Chinese Sitagliptin drug Market, 2021-2025 5.1 Influential Factors of Chinese Sitagliptin Market Development 5.1.1 The Impact of COVID-19 on Chinese Sitagliptin Market 5.1.2 Market Drivers and Opportunities 5.1.3 Market Threats and Challenges 5.2 Forecast on Market Size 5.3 Forecast on Market Trend List of Charts Chart Patent Information About Sitagliptin Tablets Registration in China Chart Sales Value of Sitagliptin Tablets over the World Chart Sales Value of Sitagliptin Tablets in China, 2016-2020 Chart Sales Value of Sitagliptin Tablets in China by Region, 2016-2020 Chart Sales Volume of Sitagliptin Tablets in China, 2016-2020 Chart Sales Volume of Sitagliptin Tablets in China by Region, 2016-2020 Chart Market Share by Sales Value of Top Sitagliptin Manufacturers in China, 2016-2020 Chart Sales Value and Volume of JANUVIA in China, 2016-2020 Chart Referential Prices of JANUVIA in China, 2020-2021 Chart Forecast on Sales Value of Sitagliptin in China, 2021-2025 Chart Forecast on Sales Volume of Sitagliptin in China, 2021-2025
Merck Sharp & Dohme Ltd
  • PRICE
  • $2600
    $3900

Our Clients